PEDIATRICS Vol. 43 No. 2 February 1969, pp. 303-304
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, S. N.
Right arrow Articles by Weber, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, S. N.
Right arrow Articles by Weber, W. W.

Newborn Infants of Tuberculous Mothers, Further Comment

Sanford N. Cohen M.D.1 and Wendell W. Weber M.D., Ph.D.2

1 Departments of Pharmacology and Pediatrics
2 Department of Pharmacology New York University School of Medicine New York, New York 10016

In their recent article, Avery and Wolfsdorf discussed INH prophylaxis of infants of tuberculous mothers and stated, "The unusual reactions of infants to many pharmacologic agents, with respect to absorption and excretion, have necessitated great care in matters of dosage and indications in infancy." The Committee on Drugs commented, in the same issue, that the pharmacology of INH has not been systematically studied in the newborn infant.

We have been studying the characteristics of the hepatic enzyme which catalyzes the acetylation of INH and sulfonamides.